Malaria vaccine (Aventis Pasteur/WRAIR)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMalaria vaccine (Aventis Pasteur/WRAIR)
Drug Alias NameNYVAC-Pf7A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria, VivaxMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Pasteur +[2] 
Active IndicationsN/A
Inactive IndicationsMalaria, VivaxMalaria, Falciparum

Other Information

ATC CodeN/A
Related LinksN/A